For example, E2 administration to ERα knockout mice bearing the Wnt-1 oncogene significantly increases mammary tumor incidence, and even in the absence of ERα, aromatase inhibitors decreased tumor formation induced by Wnt-1 [84]. Here, CYP19A1 is linked to breast cancer.